Trax’s existing use of European Sustainability Reporting Standards give pharmaceutical companies a competitive advantage in reducing scope 3 emissionsDALLAS, Jan. 09, 2024 (GLOBE NEWSWIRE) A recent McKinsey report revealed an “analysis of approximately 40 pharmaceutical companies shows that about 75 percent of emissions across the value chain are Scope 3, with 50 percent of the total emissions coming from upstream, specifically the purchased goods and services category.” Trax Technologies (Tr
Failing to reduce global supply chain footprint could cost companies $120 billion by 2026 ajot.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ajot.com Daily Mail and Mail on Sunday newspapers.